ReviewZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2024
[Research progress of metalloporphyrin against neurodegene-rative diseases].
Review in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Neurodegenerative diseases are a group of diseases caused by the degeneration and apoptosis of neurons in the brain and spinal cord, which seriously affect human ability of motion perception, memory and cognition. Peroxynitrite can cause oxidative damage in the brain by exhibiting neurotoxicity, and its excessive accumulation is closely related to neurodegenerative diseases. Therefore, effectively scavenging peroxynitrite may become a therapeutic strategy for neurodegenerative diseases. Due to their high peroxynitrite scavenging ability, water-soluble metalloporphyrins have recently attracted much attention. Metalloporphyrins such as iron porphyrins and manganese porphyrins have neuroprotective effects, including inhibiting amyloid plaque accumulation, alleviating oxidative stress and neuroinflammatory damage, improving mitochondrial function and reducing neuronal apoptosis. However, some metalloporphyrins have poor blood-brain barrier penetration. To overcome this obstacle, in addition to traditional synthesis processes, metalloporphyrins can also be prepared into nanoparticles to improve bioavailability
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.